Close menu

July 1st, 2021 | 11:12 CEST

Siemens Healthineers, Royal Helium, Linde: Three stocks with momentum

  • Helium
Photo credits:

Good health is the most valuable commodity. Especially those who have everything materially want nothing more than to remain healthy in the case of illness. People are also becoming more circumspect when it comes to preventive checkups. A few years ago, the cliché prevailed that men, in particular, gave doctors a wide berth. Today, prevention and regular checkups are considered a must. In this context, imaging techniques are becoming increasingly important: Whether an intervertebral disc or cardiovascular problem - modern medical technology equipment allows doctors to closely monitor and make the appropriate diagnoses.

time to read: 3 minutes | Author: Nico Popp

Table of contents:

    Siemens Healthineers: Breaking out to a new level

    Siemens equipment has always been well represented in radiology systems around the world. The health division of the large conglomerate was spun off in 2018 and is also listed on the stock exchange as Siemens Healthineers. Although the Company is well-positioned, Siemens Healthineers suffered from the pandemic. Many preventive checkups were postponed, or chronic patients were reluctant to go to the doctor because of the general situation. Nevertheless, the bare figures did not turn out so badly. A 10% lower profit was acceptable to even the most skeptical given the unique situation.

    The diagnostics division of Siemens Healthineers was able to profit from the pandemic. The rapid antigen tests, in particular, were in demand - the queues in front of the test centers still speak a clear language today. Should the delta variant of the virus encounter rising case numbers again in the fall, the high testing, which has declined somewhat because of low incidences, is likely to start up again. Siemens Healthineers is well-positioned and continuously rebuilding; the Company is thinking about selling its ultrasound division. Some time ago, it bought a cancer specialist in the United States. The share recently broke out to a new high and thus also looks good in the long term. Given the recent price gains, however, investors should wait a little longer. The next weakness is bound to come.

    Royal Helium: Helium specialist takes the next step

    The Royal Helium share is also going through a phase of weakness - at least if you measure the value against its highs. Royal Helium owns 400,000 hectares of promising land for helium production in the Canadian district of Saskatchewan. The Company has made news by successfully discovering helium deposits in three of three wells in recent months. Most recently, the Company secured financing of CAD 17.2 million. If the share price rises above CAD 0.75, Royal Helium could receive further funds, as the participants in the capital measure have received corresponding warrants. The financing is aimed at enabling extensive drilling and development work. Furthermore, seven new wells are planned.

    After the first successful drillings have already caused the share to jump for joy, the current level could offer an exciting opportunity for new investors. In the course of the financing and the new shares, the share price has come back a little. However, if Royal Helium continues its expansion, as it did in the first quarter, the stock should become interesting again. Helium is currently in short supply, has always been expensive, and is used in medical technology, space travel and chip production. Royal Helium is a speculative small-cap in an exciting industry.

    Linde: Positive development

    The German Company Linde is also involved in gas. The Wiesbaden-based Company is one of the leading suppliers of gases for metal processing plants, the chemical industry, the food industry, and medicine. While the industry suffered from the general conditions in 2020, Linde held up quite well. Operationally, in particular, things went well. The Group is also benefiting from the renewed rise in energy prices. These had weighed on Linde in the previous year. The shift towards sustainability could also have a negative impact on Linde in the short term. In the long term, however, development in this area can also be an opportunity. The capital market is anticipating a positive development - the share has been developing positively for a year and gained around 30%. But Linde is no longer a high-flyer.

    Gases, and especially special gases for medical technology, are an interesting field. In many places, helium and the like are only a by-product. In Saskatchewan, where Royal Helium operates, high concentrations make direct extraction a viable option. The continuing demand for medical equipment, but also for chips, and the underlying trend of rising commodity prices offer good prospects for stocks in the sector. While companies like Siemens Healthineers and Linde are very solid to dull, Royal Helium can add momentum to a portfolio. Investors should allocate such stocks according to their risk profile.

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.

    Der Autor

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author

    Related comments:

    Commented by Fabian Lorenz on May 8th, 2024 | 06:45 CEST

    BUY RECOMMENDATIONS! Are Evotec, Super Micro Computer, and Royal Helium about to take off?

    • Mining
    • Helium
    • AI
    • Biotechnology

    Evotec's share price has plummeted by around 50% this year. Consequently, the stock is among the year's losers. However, several buy recommendations are raising eyebrows. Is the turnaround imminent? The Royal Helium share is also ripe for a turnaround. The little-known noble gas is used in the defense industry, medical technology and for quantum computers, among other things. Royal Helium aims to transition from an explorer into a producer and has enlisted strong partners to achieve this. Will the share see a breakthrough after the ongoing capital increase? And what about Super Micro Computer? The AI high-flyer seems to have overcome its phase of weakness. Is it now heading for new all-time highs?


    Commented by Stefan Feulner on April 29th, 2024 | 07:15 CEST

    Newmont, Royal Helium, Anglo American - Commodities on the rise

    • Mining
    • Helium
    • Commodities
    • Gold

    Precious metals remain in demand due to geopolitical uncertainties. After gold moved away from its highs above the USD 2,400 per ounce mark, there were no further major sell-offs. Industrial metals are also still in vogue. Copper has risen by around 20% since the beginning of the year and posted a new high for the year, while nickel has moved well away from its lows for the year. On the other hand, the noble gas helium, for which a global undersupply is predicted due to rising demand from the defense industry, has seen little movement.


    Commented by André Will-Laudien on April 8th, 2024 | 07:00 CEST

    Sell AI now and buy turnaround stocks: Nel ASA, Royal Helium, Linde and Plug Power

    • Helium
    • AI
    • renewableenergies
    • chemicals

    The stock market gives and takes away. When it comes to artificial intelligence and high-tech, investors have been able to make gains of up to 600% in recent months. Stocks such as Nvidia and Super Micro Computer are on the hit list of all fund managers worldwide. However, the first quarter is over, and there is no immediate reason to continue buying overpriced AI stocks. Last Thursday saw the first shot across the bow, with the NASDAQ 100 index plummeting by over 2% within three hours. Technically, the upward momentum is already waning, leading to increased profit-taking. If many investors do it simultaneously, it will result in a hefty correction. Do not wait too long; we present some interesting reallocation ideas.